Mathew D. Ringel

Learn More
INTRODUCTION Chronic activation of the angiotensin II (AngII) type 1 receptor (AT-1) is a central event in the development of chronic kidney disease (CKD), in part through enhanced expression of TGF-beta, and AT-1 receptor blockade inhibits the progression to CKD in a variety of disease states. The AT-1 receptor is a heptahelical Gaq/11-coupled receptor(More)
The and symbols in the table of contents identify articles discussed in the Perspectives. Molecular Pharmacology (ISSN 0026-895X) is published monthly (two volumes per year beginning in January and July) by the Amer
  • 1